Author

Kaniz Fatema

Huntsman Cancer InstituteORCID 0000-0002-2560-6506Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Kaniz Fatema1 paper · World University of Bangladesh

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Ahmad Abdullah MahdeeniD· 1 shared Aminum Naher· 1 shared Ananya Majumder· 1 shared Arnob Biswas· 1 shared Bodour SalhiaiD· 1 shared David Henry LumiD· 1 shared Easin Al Rial· 1 shared Edwin LiniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Ahmad Abdullah MahdeenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsbioRxivPreprintSep 8, 2026

Integrated in silico identification of fungal-derived dual-target inhibitors for anti-schistosomal drug discovery

Tamal Paul, Md. Al-Amin, Uma Shill…·Sabrin Bashar

This paper identifies two fungal-derived compounds with dual inhibitory action against Schistosoma mansoni DHODH and cathepsin B1 using computational methods.

DOI 10.64898/2026.09.04.749322

statistical modelsimulation

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 25, 2026

Defining biologically directed therapy target signatures in urothelial carcinoma: A transcriptomic framework for precision therapy

Edwin Lin, Feng Bing-Jian, Kaniz Fatema…·Sumati Gupta

This paper identifies biologically distinct transcriptomic and proteomic patterns of ADC and immunotherapy targets in urothelial carcinoma, linking them to histologic and molecular subtypes for precision therapy.

DOI 10.64898/2026.06.24.734314

humanbulk RNA-seq

𝕏 PostBluesky